Biosignal Limited
Budapest, HU· latest recorded location
Biosignal Limited is named on 3 US grants and 0 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 0
- Inventors
- 16
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Dec 2001
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
By publication year.
Technology areas
Share of 3 documents
- A61KMedicines and medical preparations3
- A61PTherapeutic uses of medicines2
- C07CAcyclic or carbocyclic compounds2
- C07DHeterocyclic compounds2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2
Recent patents
- Treatment of platelet derived growth factor related disorders such as cancers18 Dec 2001US 6,331,555 B1
- Treatment of platelet derived growth factor related disorders such as cancers3 Aug 1999US 5,932,602 A
- Treatment of platelet derived growth factor related disorders such as cancers23 Dec 1997US 5,700,823 A
No published applications.
Most cited
By later US patents